Integra LifeSciences Holdings Corp. (IART)
13.38
+0.17
(+1.29%)
USD |
NASDAQ |
Oct 19, 15:33
Integra LifeSciences Holdings Cash from Operations (Annual) : 50.38M for Dec. 31, 2025
Cash from Operations (Annual) Chart
Historical Cash from Operations (Annual) Data
| Date | Value |
|---|---|
| December 31, 2025 | 50.38M |
| December 31, 2024 | 129.38M |
| December 31, 2023 | 139.96M |
| December 31, 2022 | 264.47M |
| December 31, 2021 | 312.43M |
| December 31, 2020 | 203.83M |
| December 31, 2019 | 231.43M |
| December 31, 2018 | 194.65M |
| December 31, 2017 | 114.54M |
| December 31, 2016 | 116.40M |
| December 31, 2015 | 104.85M |
| December 31, 2014 | 79.46M |
| December 31, 2013 | 53.27M |
| December 31, 2012 | 58.72M |
| December 31, 2011 | 104.33M |
| December 31, 2010 | 105.57M |
| Date | Value |
|---|---|
| December 31, 2009 | 143.24M |
| December 31, 2008 | 72.59M |
| December 31, 2007 | 47.03M |
| December 31, 2006 | 71.70M |
| December 31, 2005 | 56.85M |
| December 31, 2004 | 38.98M |
| December 31, 2003 | 34.83M |
| December 31, 2002 | 31.98M |
| December 31, 2001 | 15.70M |
| December 31, 2000 | -4.96M |
| December 31, 1999 | 2.502M |
| December 31, 1998 | -9.814M |
| December 31, 1997 | -7.879M |
| December 31, 1996 | -7.967M |
| December 31, 1995 | -5.642M |
Cash From Operations Definition
Represents the net cash flow from the company's business operations.
Cash from Operations (Annual) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Cash from Operations (Annual) Benchmarks
| Penumbra, Inc. | 238.66M |
| Boston Scientific Corp. | 4.534B |
| Globus Medical, Inc. | 753.45M |
| Sight Sciences, Inc. | -29.69M |
| Abbott Laboratories | 9.566B |